Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Meghna Trivedi"'
Autor:
Maitri Kalra, Elizabeth Henry, Kelly McCann, Meghan S Karuturi, Jean G Bustamante Alvarez, Amanda Parkes, Robert Wesolowski, Mei Wei, Sarah S Mougalian, Gregory Durm, Angel Qin, Caitlin Schonewolf, Meghna Trivedi, Avan J Armaghani, Frederick H Wilson, Wade T Iams, Anita A Turk, Praveen Vikas, Michael Cecchini, Sam Lubner, Priyadarshini Pathak, Kristen Spencer, Vadim S Koshkin, Matthew K Labriola, Catherine H Marshall, Katy E Beckermann, Marina N Sharifi, Anthony C Bejjani, Varsha Hotchandani, Samir Housri, Nadine Housri
Publikováno v:
JMIR Cancer, Vol 8, Iss 2, p e33859 (2022)
BackgroundExpert knowledge is often shared among multidisciplinary academic teams at tumor boards (TBs) across the country, but these conversations exist in silos and do not reach the wider oncology community. ObjectiveUsing an oncologist-only quest
Externí odkaz:
https://doaj.org/article/b5128dc2db1f4f718a05df5e4722645d
Autor:
Heather Greenlee, Margarita Santiago-Torres, Pamela Koch, Wei-Yann Tsai, Heewon L Gray, Adam M Brickman, Ann Ogden Gaffney, Martha Eddy, Cynthia A Thomson, Tracy E Crane, Naxielly Dominguez, Jhack Sepulveda, Amanda M. Marin-Chollom, Rachel Paul, Zaixing Shi, Kathleene T Ulanday, Hanjie Shen, Marisol Castellano, Yanette Fuentes, Katherine Crew, Kevin Kalinsky, Melissa Accordino, Meghna Trivedi, Bret Taback, Melissa Beauchemin, Fernando J Camacho, Daniel T Friedman, Isobel Contento, Dawn L. Hershman
Publikováno v:
Cancer Research. 82:P1-10
Purpose: Despite the benefits of diet and physical activity (PA) in improving breast cancer (BC) outcomes, few lifestyle interventions focus on Latina BC survivors who are at increased risk of cardiometabolic disorders, obesity and poor BC outcomes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17a8d9e55fe111310b6c2991258d17c5
https://doi.org/10.1158/1538-7445.sabcs21-p1-10-07
https://doi.org/10.1158/1538-7445.sabcs21-p1-10-07
Autor:
Shravan Sivakumar, Mehdi Ghasemi, Meghna Trivedi, Brian Silver, Nils Henninger, Kimiyashi Kobayashi, Adalia Jun-O’Connell
Publikováno v:
Tuesday, April 25.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1346cf338eb8dddecdb0d83170b84d9b
https://doi.org/10.1212/wnl.0000000000202317
https://doi.org/10.1212/wnl.0000000000202317
Publikováno v:
Cancer Research. 83:2477-2477
Most mortality associated with breast cancer (BC) is caused by metastasis. The metastatic process involves dissemination of tumor cells from the primary site to distant organs through the bloodstream. The tumor cells found in the bloodstream are call
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89061427eca273b1e7d604e4cb52c4c7
https://doi.org/10.1158/1538-7445.am2023-2477
https://doi.org/10.1158/1538-7445.am2023-2477
Autor:
Jason I, Griffiths, Jinfeng, Chen, Patrick A, Cosgrove, Anne, O'Dea, Priyanka, Sharma, Cynthia, Ma, Meghna, Trivedi, Kevin, Kalinsky, Kari B, Wisinski, Ruth, O'Regan, Issam, Makhoul, Laura M, Spring, Aditya, Bardia, Frederick R, Adler, Adam L, Cohen, Jeffrey T, Chang, Qamar J, Khan, Andrea H, Bild
Publikováno v:
Nature cancer
Combining cyclin-dependent kinase (CDK) inhibitors with endocrine therapy improves outcomes for metastatic estrogen receptor positive (ER+) breast cancer patients but its value in earlier stage patients is unclear. We examined evolutionary trajectori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a81880835a05ca44149a2b8326702633
https://pubmed.ncbi.nlm.nih.gov/34712959
https://pubmed.ncbi.nlm.nih.gov/34712959
Autor:
Emily I Chen, Katherine D Crew, Meghna Trivedi, Danielle Awad, Mathew Maurer, Kevin Kalinsky, Antonius Koller, Purvi Patel, Jenny Kim Kim, Dawn L Hershman
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145816 (2015)
Major advances in early detection and therapy have significantly increased the survival of breast cancer patients. Unfortunately, most cancer therapies are known to carry a substantial risk of adverse long-term treatment-related effects. Little is kn
Externí odkaz:
https://doaj.org/article/0a2fd7a3941a44308260bd2884f38fdd
Autor:
Madeleine B. Hopson, Shing Lee, Melissa Accordino, Meghna Trivedi, Matthew Maurer, Katherine Crew, Dawn Hershman, Kevin Kalinsky
Purpose: Propranolol regulates angiogenesis in pre-clinical models and reduces distant breast cancer (BC) metastases in observational studies. We assessed the feasibility of combining propranolol with neoadjuvant chemotherapy (NAC) in patients with B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7ba07d2b26e76a049054e37cacd1ccf
https://doi.org/10.21203/rs.3.rs-162839/v1
https://doi.org/10.21203/rs.3.rs-162839/v1
Chemoprotective effect of metformin against HR+/HER2- breast cancer among women with type-2 diabetes
Autor:
Meghna Trivedi, Soumya Chikermane, Susan Abughosh, Michael L. Johnson, Manvi Sharma, Rajender R. Aparasu
Publikováno v:
Journal of Clinical Oncology. 39:10518-10518
10518 Background: Type-2 diabetes mellitus (T2DM) increases the risk of breast cancer among postmenopausal women. Metformin has demonstrated a chemoprotective effect in breast cancer, however its role in HR+/HER2- breast cancer (HR+/HER2- BC), the mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba879511b8b9b83a7b9423bb99f2b240
https://doi.org/10.1200/jco.2021.39.15_suppl.10518
https://doi.org/10.1200/jco.2021.39.15_suppl.10518
Autor:
Ming Hu, Romi Ghose, Pankajini Mallick, Michael M. Ittmann, Pranav Shah, Meghna Trivedi, Song Gao
Publikováno v:
Chemico-biological interactions. 291
Irinotecan is highly effective in the treatment of metastatic colorectal cancer as well as many other cancers. However, irinotecan is known to cause severe diarrhea, which pose significant problems in patients undergoing irinotecan based chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c171d9a1fe55ee3df9097cbce8cbf48
https://pubmed.ncbi.nlm.nih.gov/29913120
https://pubmed.ncbi.nlm.nih.gov/29913120
Autor:
Haeseung, Yi, Tong, Xiao, Parijatham S, Thomas, Alejandra N, Aguirre, Cindy, Smalletz, Jill, Dimond, Joseph, Finkelstein, Katherine, Infante, Meghna, Trivedi, Raven, David, Jennifer, Vargas, Katherine D, Crew, Rita, Kukafka
Publikováno v:
AMIA ... Annual Symposium proceedings. AMIA Symposium. 2015
The purpose of this study was to identify barriers and facilitators to patient-provider communication when discussing breast cancer risk to aid in the development of decision support tools. Four patient focus groups (N=34) and eight provider focus gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0ef18c04d14305394f855beda2708a0
https://pubmed.ncbi.nlm.nih.gov/26958276
https://pubmed.ncbi.nlm.nih.gov/26958276